Abstract
1 Oral doses of BW501 and methysergide administered to healthy volunteers inhibited the ex vivo platelet aggregation response to 5-hydroxytryptamine (5-HT). 2 Two volunteers received 100 mg BW501 and two received 10 mg BW501 and aggregation response was measured immediately pre drug and at 1,3 and 24 h post drug. After 100 mg BW501 the response to 5-HT was completely inhibited at all times studied, after 10 BW501 a response too small to measure was apparent at 24 h only. 3 In two randomised crossover studies subjects received either 2 mg BW501 (nine subjects), 2 mg methysergide (six subjects) or no drug (nine subjects) and aggregation response to 5-HT was measured immediately pre drug and at 1, 2, 3, 5, 7, 24 h post drug. 4 Methysergide (2 mg) produced complete inhibition of aggregation for 24 h after dosing; following 2 mg BW501 the aggregation response was significantly lower than on the control occasion at 1 (P less than 0.01), 2 (P less than 0.01) and 3 (P less than 0.05) h post drug. The response was inhibited by rr%, 31% and 16% at these times respectively. 5 It is suggested that this technique provides a suitable method for demonstration of activity of 5-HT antagonists after oral dosing in man.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
- Hilton B. P., Cumings J. N. An assessment of platelet aggregation induced by 5-hydroxytryptamine. J Clin Pathol. 1971 Apr;24(3):250–258. doi: 10.1136/jcp.24.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hilton B. P., Zilkha K. J. Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects. J Neurol Neurosurg Psychiatry. 1974 May;37(5):593–597. doi: 10.1136/jnnp.37.5.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mawson C., Whittington H. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol. 1970 May;39(1):223P–224P. [PMC free article] [PubMed] [Google Scholar]